Mandate

Vinge advises Capio in connection with acquisition of Backa Läkarhus

January 05, 2017

The operations had a turnover of approximately MSEK 345 in 2016, and have 83 000 listed patients. Closing is subject to customary closing conditions from the relevant county councils and unconditional approval from the Swedish Competition Authority. The enterprise value amounts to MSEK 300.

Vinge’s team primarily consists of client responsible partner Anders Strid, Frida Bäckegren (project leader M&A), Lina André and Jonas Lindblad (employment), Gabriella Fossum (procurement), Mercedes Anderås (real estate), Camilla Andersson (corporate) as well as Pär Remnelid, among others (competition).

Related

Vinge advised Precise Biometrics

Vinge has advised Precise Biometrics AB in connection with the merger with Fingerprint Cards.
March 27, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 83 million before transaction costs, with an over-allotment issue of approximately SEK 30 million.
March 26, 2026

Vinge advises Diamyd Medical in connection with directed issuances of shares and warrants of up to SEK 1,166 million

Vinge advises Diamyd Medical Aktiebolag (“Diamyd Medical”), listed on Nasdaq First North Growth Market, in connection with directed issuances of shares and warrants whereby Diamyd Medical receives gross proceeds of approximately SEK 1,166 million, if all warrants are exercised.
March 25, 2026